# Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

> **NCT06255379** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Guangzhou University of Traditional Chinese Medicine** · enrollment: 52 (estimated)

## Conditions studied

- Metastasis Colorectal Cancer
- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** Fuquinitinib+Tegafur Gimeracil Oteracil

## Key facts

- **NCT ID:** NCT06255379
- **Lead sponsor:** Guangzhou University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-06
- **Primary completion:** 2027-03-21
- **Final completion:** 2027-03-21
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06255379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06255379, "Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06255379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*